Literature DB >> 10970372

Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG.

D C Dillon1, M R Alderson, C H Day, T Bement, A Campos-Neto, Y A Skeiky, T Vedvick, R Badaro, S G Reed, R Houghton.   

Abstract

In order to identify antigens that may be used in the serodiagnosis of active tuberculosis (TB), we screened a Mycobacterium tuberculosis genomic expression library with a pool of sera from patients diagnosed with active pulmonary TB. The sera used lacked reactivity with a recombinant form of the M. tuberculosis 38-kDa antigen (r38kDa), and the goal was to identify antigens that might complement r38kDa in a serodiagnostic assay. Utilizing this strategy, we identified a gene, previously designated lhp, which encodes a 100-amino-acid protein referred to as culture filtrate protein 10 (CFP-10). The lhp gene is located directly upstream of esat-6, within a region missing in M. bovis BCG. Immunoblot analysis demonstrated that CFP-10 is present in M. tuberculosis CFP, indicating that it is likely a secreted or shed antigen. Purified recombinant CFP-10 (rCFP-10) was shown to be capable of detecting specific antibody in a percentage of TB patients that lack reactivity with r38kDa, most notably in smear-negative cases, where sensitivity was increased from 21% for r38kDa alone to 40% with the inclusion of rCFP-10. In smear-positive patient sera, sensitivity was increased from 49% for r38kDa alone to 58% with the inclusion of rCFP-10. In addition, rCFP-10 was shown to be a potent T-cell antigen, eliciting proliferative responses and gamma interferon production from peripheral blood mononuclear cells in 70% of purified protein derivative-positive individuals without evident disease. The responses to this antigen argue for the inclusion of rCFP-10 in a polyvalent serodiagnostic test for detection of active TB infection. rCFP-10 could also contribute to the development of a recombinant T-cell diagnostic test capable of detecting exposure to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970372      PMCID: PMC87375     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis.

Authors:  R C Hendrickson; J F Douglass; L D Reynolds; P D McNeill; D Carter; S G Reed; R L Houghton
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation.

Authors:  C Espitia; I Cervera; R González; R Mancilla
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

3.  Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis.

Authors:  P S Jackett; G H Bothamley; H V Batra; A Mistry; D B Young; J Ivanyi
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  The immunodominant 38-kDa lipoprotein antigen of Mycobacterium tuberculosis is a phosphate-binding protein.

Authors:  Z Chang; A Choudhary; R Lathigra; F A Quiocho
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens.

Authors:  R L Skjøt; T Oettinger; I Rosenkrands; P Ravn; I Brock; S Jacobsen; P Andersen
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis.

Authors:  A B Andersen; E B Hansen
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

8.  Detection of lipoarabinomannan as a diagnostic test for tuberculosis.

Authors:  E Sada; D Aguilar; M Torres; T Herrera
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Clinical evaluation of a serological assay using a monoclonal antibody (TB72) to the 38 kDa antigen of Mycobacterium tuberculosis.

Authors:  G H Bothamley; R M Rudd
Journal:  Eur Respir J       Date:  1994-02       Impact factor: 16.671

10.  Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells.

Authors:  M R Alderson; T Bement; C H Day; L Zhu; D Molesh; Y A Skeiky; R Coler; D M Lewinsohn; S G Reed; D C Dillon
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  47 in total

1.  Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis.

Authors:  W Florio; D Bottai; G Batoni; S Esin; M Pardini; G Maisetta; M Campa
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling.

Authors:  Si Guo; Lang Bao; Zi Fang Qin; Xin Xin Shi
Journal:  Med Microbiol Immunol       Date:  2010-03-16       Impact factor: 3.402

Review 3.  Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Authors:  Karen R Steingart; Nandini Dendukuri; Megan Henry; Ian Schiller; Payam Nahid; Philip C Hopewell; Andrew Ramsay; Madhukar Pai; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

4.  ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.

Authors:  Xisheng Wang; Peter F Barnes; Karen M Dobos-Elder; James C Townsend; Yoon-tae Chung; Homayoun Shams; Stephen E Weis; Buka Samten
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

5.  Association of strong immune responses to PPE protein Rv1168c with active tuberculosis.

Authors:  Nooruddin Khan; Kaiser Alam; Shiny Nair; Vijaya Lakshmi Valluri; Kolluri J R Murthy; Sangita Mukhopadhyay
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

6.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release.

Authors:  B Singh; G Singh; V Trajkovic; P Sharma
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 8.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

9.  Humoral immune responses against the Mycobacterium tuberculosis 38-kilodalton, MTB48, and CFP-10/ESAT-6 antigens in tuberculosis.

Authors:  Xueqiong Wu; Yourong Yang; Junxian Zhang; Bangying Li; Yan Liang; Chuiying Zhang; Mei Dong; Hongbing Cheng; Jufang He
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

10.  Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.

Authors:  Steven G Reed; Rhea N Coler; Wilfried Dalemans; Wilifred Dalemans; Esterlina V Tan; Eduardo C DeLa Cruz; Randall J Basaraba; Ian M Orme; Yasir A W Skeiky; Mark R Alderson; Karen D Cowgill; Jean-Paul Prieels; Rodolfo M Abalos; Marie-Claude Dubois; Joe Cohen; Pascal Mettens; Yves Lobet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.